The University of Southampton
University of Southampton Institutional Repository

Ten-Year All-Cause Death According to Completeness of Revascularization in Patients With Three-Vessel Disease or Left Main Coronary Artery Disease: Insights From the SYNTAX Extended Survival Study

Ten-Year All-Cause Death According to Completeness of Revascularization in Patients With Three-Vessel Disease or Left Main Coronary Artery Disease: Insights From the SYNTAX Extended Survival Study
Ten-Year All-Cause Death According to Completeness of Revascularization in Patients With Three-Vessel Disease or Left Main Coronary Artery Disease: Insights From the SYNTAX Extended Survival Study

BACKGROUND: Ten-year all-cause death according to incomplete (IR) versus complete revascularization (CR) has not been fully investigated in patients with 3-vessel disease and left main coronary artery disease undergoing percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG).

METHODS: The SYNTAX Extended Survival study (Synergy Between PCI With TAXUS and Cardiac Surgery: SYNTAX Extended Survival [SYNTAXES]) evaluated vital status up to 10 years in patients who were originally enrolled in the SYNTAX trial. In the present substudy, outcomes of the CABG CR group were compared with the CABG IR, PCI CR, and PCI IR groups. In addition, in the PCI cohort, the residual SYNTAX score (rSS) was used to quantify the extent of IR and to assess its association with fatal late outcome. The rSS of 0 suggests CR, whereas a rSS>0 identifies the degree of IR.

RESULTS: IR was more frequently observed in patients with PCI versus CABG (56.6% versus 36.8%) and more common in those with 3-vessel disease than left main coronary artery disease in both the PCI arm (58.5% versus 53.8%) and the CABG arm (42.8% versus 27.5%). Patients undergoing PCI with CR had no significant difference in 10-year all-cause death compared with those undergoing CABG (22.2% for PCI with CR versus 24.3% for CABG with IR versus 23.8% for CABG with CR). In contrast, those with PCI and IR had a significantly higher risk of all-cause death at 10 years compared with CABG and CR (33.5% versus 23.7%; adjusted hazard ratio, 1.48 [95% CI, 1.15-1.91]). When patients with PCI were stratified according to the rSS, those with a rSS≤8 had no significant difference in all-cause death at 10 years as the other terciles (22.2% for rSS=0 versus 23.9% for rSS>0-4 versus 28.9% for rSS>4-8), whereas a rSS>8 had a significantly higher risk of 10-year all-cause death than those undergoing PCI with CR (50.1% versus 22.2%; adjusted hazard ratio, 3.40 [95% CI, 2.13-5.43]).

CONCLUSIONS: IR is common after PCI, and the degree of incompleteness was associated with 10-year mortality. If it is unlikely that complete (or nearly complete; rSS<8) revascularization can be achieved with PCI in patients with 3-vessel disease, CABG should be considered. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT00114972. URL: https://www.clinicaltrials.gov; Unique identifier: NCT03417050.

coronary artery bypass, coronary artery disease, myocardial revascularization, percutaneous coronary intervention
0009-7322
96-109
Takahashi, Kuniaki
ce404370-6f8b-443b-bd9f-ac499723f473
Serruys, Patrick W
98dfd61b-78fb-4f77-9995-7d9959332961
Gao, Chao
249a2c6e-cf9a-4463-bd78-0f2ad7a17a3a
Ono, Masafumi
6aea6fe1-65c8-4747-864d-3b09797e7af8
Wang, Rutao
709e794d-93c0-4564-a817-b7c8ad0683fe
Thuijs, Daniel J F M
a20f778e-a98b-478d-a848-a41446f4d707
Mack, Michael J
5fb155bd-62b4-46f4-b1ae-47f594673497
Curzen, Nick
70f3ea49-51b1-418f-8e56-8210aef1abf4
Mohr, Friedrich-Wilhelm
96ed2d2f-5332-47dc-a2cb-67afe8ba319e
Davierwala, Piroze
ca3ecf52-ca3c-4cd5-89f4-9a0ef4293d59
Milojevic, Milan
2cc58dab-3afb-45d5-b860-01cd32bf39db
Wykrzykowska, Joanna J
7f1370a3-8611-4974-9ee6-762884244eb0
de Winter, Robbert J
d862390c-022f-4772-a0b0-26d4e1ae5abd
Sharif, Faisal
af411836-417d-4394-b913-b4b09002e66f
Onuma, Yoshinobu
3bae88ea-1afa-43b2-bbd0-a68d72d78662
Head, Stuart J
4f1afb04-0961-4c67-b6bf-cd1c786aca8f
Kappetein, Arie Pieter
32f2d1de-8630-4a3c-a3b8-2db139882bb6
Morice, Marie-Claude
8fad799e-b853-419c-a534-c570471dad6f
Holmes, David R
66df9a84-7b58-4212-a41f-4154a8361203
SYNTAX Extended Survival Study Investigators
Takahashi, Kuniaki
ce404370-6f8b-443b-bd9f-ac499723f473
Serruys, Patrick W
98dfd61b-78fb-4f77-9995-7d9959332961
Gao, Chao
249a2c6e-cf9a-4463-bd78-0f2ad7a17a3a
Ono, Masafumi
6aea6fe1-65c8-4747-864d-3b09797e7af8
Wang, Rutao
709e794d-93c0-4564-a817-b7c8ad0683fe
Thuijs, Daniel J F M
a20f778e-a98b-478d-a848-a41446f4d707
Mack, Michael J
5fb155bd-62b4-46f4-b1ae-47f594673497
Curzen, Nick
70f3ea49-51b1-418f-8e56-8210aef1abf4
Mohr, Friedrich-Wilhelm
96ed2d2f-5332-47dc-a2cb-67afe8ba319e
Davierwala, Piroze
ca3ecf52-ca3c-4cd5-89f4-9a0ef4293d59
Milojevic, Milan
2cc58dab-3afb-45d5-b860-01cd32bf39db
Wykrzykowska, Joanna J
7f1370a3-8611-4974-9ee6-762884244eb0
de Winter, Robbert J
d862390c-022f-4772-a0b0-26d4e1ae5abd
Sharif, Faisal
af411836-417d-4394-b913-b4b09002e66f
Onuma, Yoshinobu
3bae88ea-1afa-43b2-bbd0-a68d72d78662
Head, Stuart J
4f1afb04-0961-4c67-b6bf-cd1c786aca8f
Kappetein, Arie Pieter
32f2d1de-8630-4a3c-a3b8-2db139882bb6
Morice, Marie-Claude
8fad799e-b853-419c-a534-c570471dad6f
Holmes, David R
66df9a84-7b58-4212-a41f-4154a8361203

SYNTAX Extended Survival Study Investigators (2021) Ten-Year All-Cause Death According to Completeness of Revascularization in Patients With Three-Vessel Disease or Left Main Coronary Artery Disease: Insights From the SYNTAX Extended Survival Study. Circulation, 144 (2), 96-109. (doi:10.1161/CIRCULATIONAHA.120.046289).

Record type: Article

Abstract

BACKGROUND: Ten-year all-cause death according to incomplete (IR) versus complete revascularization (CR) has not been fully investigated in patients with 3-vessel disease and left main coronary artery disease undergoing percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG).

METHODS: The SYNTAX Extended Survival study (Synergy Between PCI With TAXUS and Cardiac Surgery: SYNTAX Extended Survival [SYNTAXES]) evaluated vital status up to 10 years in patients who were originally enrolled in the SYNTAX trial. In the present substudy, outcomes of the CABG CR group were compared with the CABG IR, PCI CR, and PCI IR groups. In addition, in the PCI cohort, the residual SYNTAX score (rSS) was used to quantify the extent of IR and to assess its association with fatal late outcome. The rSS of 0 suggests CR, whereas a rSS>0 identifies the degree of IR.

RESULTS: IR was more frequently observed in patients with PCI versus CABG (56.6% versus 36.8%) and more common in those with 3-vessel disease than left main coronary artery disease in both the PCI arm (58.5% versus 53.8%) and the CABG arm (42.8% versus 27.5%). Patients undergoing PCI with CR had no significant difference in 10-year all-cause death compared with those undergoing CABG (22.2% for PCI with CR versus 24.3% for CABG with IR versus 23.8% for CABG with CR). In contrast, those with PCI and IR had a significantly higher risk of all-cause death at 10 years compared with CABG and CR (33.5% versus 23.7%; adjusted hazard ratio, 1.48 [95% CI, 1.15-1.91]). When patients with PCI were stratified according to the rSS, those with a rSS≤8 had no significant difference in all-cause death at 10 years as the other terciles (22.2% for rSS=0 versus 23.9% for rSS>0-4 versus 28.9% for rSS>4-8), whereas a rSS>8 had a significantly higher risk of 10-year all-cause death than those undergoing PCI with CR (50.1% versus 22.2%; adjusted hazard ratio, 3.40 [95% CI, 2.13-5.43]).

CONCLUSIONS: IR is common after PCI, and the degree of incompleteness was associated with 10-year mortality. If it is unlikely that complete (or nearly complete; rSS<8) revascularization can be achieved with PCI in patients with 3-vessel disease, CABG should be considered. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT00114972. URL: https://www.clinicaltrials.gov; Unique identifier: NCT03417050.

This record has no associated files available for download.

More information

Accepted/In Press date: 12 April 2020
e-pub ahead of print date: 20 May 2021
Published date: 13 July 2021
Keywords: coronary artery bypass, coronary artery disease, myocardial revascularization, percutaneous coronary intervention

Identifiers

Local EPrints ID: 453251
URI: http://eprints.soton.ac.uk/id/eprint/453251
ISSN: 0009-7322
PURE UUID: 78d337d1-5ebe-4aa1-8fbd-c0e263e3b485
ORCID for Nick Curzen: ORCID iD orcid.org/0000-0001-9651-7829

Catalogue record

Date deposited: 11 Jan 2022 17:47
Last modified: 17 Mar 2024 03:02

Export record

Altmetrics

Contributors

Author: Kuniaki Takahashi
Author: Patrick W Serruys
Author: Chao Gao
Author: Masafumi Ono
Author: Rutao Wang
Author: Daniel J F M Thuijs
Author: Michael J Mack
Author: Nick Curzen ORCID iD
Author: Friedrich-Wilhelm Mohr
Author: Piroze Davierwala
Author: Milan Milojevic
Author: Joanna J Wykrzykowska
Author: Robbert J de Winter
Author: Faisal Sharif
Author: Yoshinobu Onuma
Author: Stuart J Head
Author: Arie Pieter Kappetein
Author: Marie-Claude Morice
Author: David R Holmes
Corporate Author: SYNTAX Extended Survival Study Investigators

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×